Mayank Mamtani
Stock Analyst at B. Riley Securities
(4.10)
# 1,630
Out of 5,051 analysts
1079
Total ratings
38.8%
Success rate
6.5%
Average return
Main Sectors:
Stocks Rated by Mayank Mamtani
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LCTX Lineage Cell Therapeutics | Maintained: Buy | $4 | $0.9478 | +322.03% | 18 | Sep 25, 2026 | |
| AGEN Agenus | Reiterated: Buy | $14 | $8.50 | +64.71% | 83 | Sep 24, 2026 | |
| ELTX Elicio Therapeutics | Reiterated: Buy | $27 → $8 | $1.88 | +325.53% | 2 | Sep 24, 2026 | |
| CUE Cue Biopharma | Initiated Coverage: Buy | $83 | $32.85 | +152.66% | 1 | Sep 18, 2026 | |
| XGN Exagen | Reiterated: Buy | $12 | $8.74 | +37.30% | 1 | Sep 11, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | $26 → $30 | $11.89 | +152.31% | 2 | Sep 4, 2026 | |
| AAPG Ascentage Pharma Group International | Reiterated: Buy | $45 | $15.23 | +195.47% | 2 | Sep 2, 2026 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Initiated Coverage: Buy | $15.52 | $2.43 | +538.72% | 1 | Aug 26, 2026 | |
| DNLI Denali Therapeutics | Reiterated: Buy | $30 → $35 | $20.47 | +70.98% | 26 | Aug 25, 2026 | |
| MGNX MacroGenics | Reiterated: Buy | $9 → $11 | $3.80 | +189.47% | 10 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $20 | $4.81 | +315.80% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $33.10 | +81.27% | 30 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $44 | $26.81 | +64.12% | 5 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $5.73 | +144.33% | 4 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 → $31 | $14.68 | +111.24% | 23 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 → $146 | $65.66 | +122.36% | 24 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $170 | $115.72 | +46.91% | 1 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $117 → $155 | $115.78 | +33.87% | 4 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $30.10 | +49.50% | 6 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $10.60 | +69.81% | 118 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.8001 | +274.95% | 16 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $6.32 | +89.87% | 2 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $14.12 | +55.81% | 25 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $150 | $59.38 | +152.61% | 9 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $7.45 | n/a | 3 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $33 | $17.97 | n/a | 2 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $55 | $57.52 | n/a | 65 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.62 | n/a | 1 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $12.30 | n/a | 5 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $18 | $3.04 | n/a | 71 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $36.75 | n/a | 34 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $66.07 | n/a | 78 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $422 → $460 | $513.08 | n/a | 57 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 → $2 | $0.48 | n/a | 35 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 → $2 | $0.9508 | n/a | 23 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $59.49 | n/a | 1 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.28 | n/a | 30 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.5262 | n/a | 15 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.04 | n/a | 16 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $140 | $4.94 | n/a | 4 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $4 | $3.00 | n/a | 25 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.61 | n/a | 16 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7728 | n/a | 23 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.001 | n/a | 10 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.84 | n/a | 8 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.00 | n/a | 14 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 14 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.65 | n/a | 14 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.14 | n/a | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $120 | $16.00 | n/a | 7 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $10 | $9.57 | n/a | 14 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 | $38.58 | n/a | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.88 | n/a | 26 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.10 | n/a | 19 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0005 | n/a | 7 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.96 | n/a | 7 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.16 | n/a | 10 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.05 | n/a | 4 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.71 | n/a | 1 | May 12, 2020 |
Lineage Cell Therapeutics
Sep 25, 2026
Maintained: Buy
Price Target: $4
Current: $0.9478
Upside: +322.03%
Agenus
Sep 24, 2026
Reiterated: Buy
Price Target: $14
Current: $8.50
Upside: +64.71%
Elicio Therapeutics
Sep 24, 2026
Reiterated: Buy
Price Target: $27 → $8
Current: $1.88
Upside: +325.53%
Cue Biopharma
Sep 18, 2026
Initiated Coverage: Buy
Price Target: $83
Current: $32.85
Upside: +152.66%
Exagen
Sep 11, 2026
Reiterated: Buy
Price Target: $12
Current: $8.74
Upside: +37.30%
Climb Bio
Sep 4, 2026
Reiterated: Buy
Price Target: $26 → $30
Current: $11.89
Upside: +152.31%
Ascentage Pharma Group International
Sep 2, 2026
Reiterated: Buy
Price Target: $45
Current: $15.23
Upside: +195.47%
Cardiol Therapeutics Inc.
Aug 26, 2026
Initiated Coverage: Buy
Price Target: $15.52
Current: $2.43
Upside: +538.72%
Denali Therapeutics
Aug 25, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $20.47
Upside: +70.98%
MacroGenics
Aug 17, 2026
Reiterated: Buy
Price Target: $9 → $11
Current: $3.80
Upside: +189.47%
Aug 13, 2026
Reiterated: Buy
Price Target: $22 → $20
Current: $4.81
Upside: +315.80%
Aug 10, 2026
Reiterated: Buy
Price Target: $60
Current: $33.10
Upside: +81.27%
Aug 10, 2026
Reiterated: Buy
Price Target: $40 → $44
Current: $26.81
Upside: +64.12%
Aug 7, 2026
Reiterated: Buy
Price Target: $12 → $14
Current: $5.73
Upside: +144.33%
Aug 7, 2026
Initiated Coverage: Buy
Price Target: $16 → $31
Current: $14.68
Upside: +111.24%
Jul 31, 2026
Reiterated: Buy
Price Target: $108 → $146
Current: $65.66
Upside: +122.36%
Jul 15, 2026
Initiated Coverage: Buy
Price Target: $170
Current: $115.72
Upside: +46.91%
Jun 29, 2026
Rated: Buy
Price Target: $117 → $155
Current: $115.78
Upside: +33.87%
May 29, 2026
Reiterated: Buy
Price Target: $45
Current: $30.10
Upside: +49.50%
Apr 9, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $10.60
Upside: +69.81%
Apr 7, 2026
Reiterated: Buy
Price Target: $3
Current: $0.8001
Upside: +274.95%
Mar 26, 2026
Rated: Buy
Price Target: $12
Current: $6.32
Upside: +89.87%
Mar 18, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $14.12
Upside: +55.81%
Feb 23, 2026
Reiterated: Buy
Price Target: $105 → $150
Current: $59.38
Upside: +152.61%
Oct 6, 2025
Reiterated: Buy
Price Target: $28
Current: $7.45
Upside: n/a
Oct 3, 2025
Reiterated: Buy
Price Target: $29 → $33
Current: $17.97
Upside: n/a
Sep 17, 2025
Reiterated: Buy
Price Target: $53 → $55
Current: $57.52
Upside: n/a
Aug 26, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $0.62
Upside: n/a
Aug 19, 2025
Reiterated: Buy
Price Target: $43
Current: $12.30
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $20 → $18
Current: $3.04
Upside: n/a
Jul 15, 2025
Reiterated: Buy
Price Target: $85
Current: $36.75
Upside: n/a
May 14, 2025
Reiterated: Buy
Price Target: $38
Current: $66.07
Upside: n/a
May 2, 2025
Reiterated: Buy
Price Target: $422 → $460
Current: $513.08
Upside: n/a
Mar 27, 2025
Reiterated: Buy
Price Target: $2.5 → $2
Current: $0.48
Upside: n/a
Feb 6, 2025
Reiterated: Buy
Price Target: $1.5 → $2
Current: $0.9508
Upside: n/a
Jan 9, 2025
Initiated Coverage: Buy
Price Target: $21
Current: $59.49
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $2.28
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $0.5262
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $1.04
Upside: n/a
Jun 14, 2024
Reiterated: Buy
Price Target: $4 → $140
Current: $4.94
Upside: n/a
May 17, 2023
Reiterated: Buy
Price Target: $3 → $4
Current: $3.00
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $1.61
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.7728
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.001
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.84
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $2.00
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 15, 2022
Reiterated: Buy
Price Target: $6
Current: $2.65
Upside: n/a
Aug 19, 2022
Rated: Hold
Price Target: n/a
Current: $1.14
Upside: n/a
Mar 31, 2022
Reiterated: Buy
Price Target: $3 → $120
Current: $16.00
Upside: n/a
Mar 23, 2022
Reiterated: Buy
Price Target: $17 → $10
Current: $9.57
Upside: n/a
Nov 12, 2021
Reiterated: Buy
Price Target: $67
Current: $38.58
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $4.88
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $10.10
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $0.0005
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $3.96
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $2.16
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $9.05
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $15.71
Upside: n/a